The natural history of hepatitis C

Bailliere's Clinical Gastroenterology

Volumn 10, Issue 2, 1996, Pages 275-288

  Colombo, Massimo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC HEPATITIS; CRYOGLOBULINEMIA; DISEASE COURSE; DISEASE SEVERITY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK; VIRUS REPLICATION;

EID: 0029766206     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(96)90007-X     Document Type: Article

References (75)

1. Aach RD, Stevens CE, Hollinger FB et al (1991) Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. New England Journal of Medicine 325: 1325-1329.
2. Agnello V, Chung RT & Kaplan LM (1992) A role for hepatitis C virus infection in type II cryo-globulinemia. New England Journal of Medicine 327: 1490-1495.
3. Alberti A (1991) Diagnosis of hepatitis C. Facts and perspectives. Journal of Hepatology 12: 279-282.
4. Alberti A, Morsica G, Chemello L et al (1992) Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet 340: 697-698.
5. Alter HJ, Purcell RH, Shih JW et al (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England Journal of Medicine 321: 1494-1500
6. Alter MJ, Margolis HS, Krawczynski K et al (1992) The natural history of community-acquired hepatitis C in the United States. New England Journal of Medicine 327: 1899-1905.
7. Barrera JM, Bruguera M, Ercilla MG et al (1995) Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21: 639-644.
8. Bellman B, Reddy KR & Falanga V (1995) Lichen planus associated with hepatitis C. Lancet 346: 1234.
9. Benvegnù L, Fattovich G, Noventa F et al (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74: 2442-2448.
10. Bortolotti F, Jara P, Diaz C et al (1994) Posttransfusion and community-acquired hepatitis C in childhood. Journal of Pediatric Gastroenterologic Nutrition 18: 279-283.
11. Brillanti S, Garson JA, Tuke PW et al (1991) Effect of Interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study. Journal of Medical Virology 34: 136-141.
12. Brillanti S, Foli M, Gaiani S et al (1993) Persistent hepatitis C viraemia without liver disease. Lancet 341: 464-465.
13. Chan TM, Lok ASF, Cheng IKP & Chan R (1993) A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104: 862-868.
14. Chazouilleres O, Kim M, Combs C et al (1994) Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 106: 994-999.
15. Chen DS, Kuo G, Sung JL et al (1990) Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. Journal of Infectious Diseases 162: 817-822.
16. Colombo M (1993) Hepatocellular carcinoma in cirrhotics. Seminars in Liver Disease 13: 374-383.
17. Colombo M, de Franchis R, Del Ninno E et al (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. New England Journal of Medicine 325: 675-680.
18. De Mitri MS, Poussin K, Baccarini P et al (1994) HCV-associated liver cancer without cirrhosis. Lancet 345: 413-415.
19. Deny P, Bonacorsi S, Guillevin L & Quint L (1992) Association between hepatitis C virus and polyarteritis nodosa. Clinical and Experimental Rheumatology 10: 319.
20. Di Bisceglie AM, Goodman WD, Ishak KG et al (1991) Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 14: 696-974.
21. Esteban-Mur JI (1990) Viral hepatitis C: progression to chronicity. Second International Symposium of HCV, p 30. Abstract.
22. Eyster ME, Diamondstone LS, Lien JM et al (1993) Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes 6: 602-610.
23. Fagan AE (1994) Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology 19: 1307-1312.
24. Farci P, Alter HJ, Wong D et al (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. New England Journal of Medicine 325: 98-104.
25. Feray C, Gigou M, Samuel D et al (1994) The course of hepatitis C virus infection after liver transplantation. Hepatology 20: 1137-1143.
26. Haddad J, Deny P, Munz-Gotheil C et al (1992) Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339: 321-323.
27. Hagiwara H, Hayashi N, Nita E et al (1993) Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 17: 545-550.
28. Hanafusa T, Ichikawa Y, Kyo M et al (1995) Long-term impact of hepatitis virus infection on kidney transplantant recipient and a pilot study of the effects of interferon alpha on chronic hepatitis C. Transplantation Proceedings 27: 956-957.
29. Hay CRM, Preston FE, Triger DR & Underwood JCE (1985) Progressive liver disease in haemophilia: an understated problem? Lancet i: 1495-1498.
30. Herrero C, Vicente A, Bruguera M et al (1993) Is hepatitis C virus infection a trigger of porphiria cutanea tarda? Lancet 341: 788-789.
31. Honda M, Kaneko S, Sakai A et al (1994) Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20: 1144-1151.
32. Hwang SJ, Lee SD, Chan CY et al (1994) A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. Journal of Hepatology 21: 831-836.
33. Inui A, Fujisawa T, Miyagawa Y et al (1994) Histologic activity of the liver in children with transfusion-associated chronic hepatitis C. Journal of Hepatology 21: 748-753.
34. Johnson RJ, Grecht DR, Yamabe H et al (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. New England Journal of Medicine 328: 465-470.
35. Jubert C, Pawlotsky JM, Ponget F et al (1994) Lichen planus and hepatitis C virus related chronic active hepatitis. Archives of Dermatology 130: 73-76.
36. Kanamori H, Fukawa H, Maruta A et al (1992) Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. American Journal of the Medical Sciences 303: 109-111.
37. Kato N, Yokosuka O, Hosoda K et al (1993) Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 18: 16-20.
38. Kiyosawa K, Sodeyama T, Tanaka E et al (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671-675.
39. Koretz RL, Abber H, Coleman E & Gitnick G (1993) Non-A, non-B post-transfusion hepatitis. Annals of Internal Medicine 119: 110-115.
40. Koziel MJ, Dudley D, Afdahl N et al (1992) Hepatitis C virus (HCV)-specilic cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. Journal of Virology 67: 7522-7532.
41. Lampertico P, Rumi MG, Romeo R et al (1994) A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C. Hepatology 19: 19-22.
42. Lau JYN, Davis GL, Kniffen J et al (1993) Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341: 1501-1504.
43. Liang TJ, Jeffers L, Reddy RK et al (1993) Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 104: 556-562.
44. Mattsson L, Grillner L & Weiland O (1992) Seroconversion to hepatitis C virus antibodies in patients with acute post-transfusion non-A, non-B hepatitis in Sweden with a second-generation test. Scandinavian Journal of Infectious Diseases 24: 15-20.
45. Mendenhall CL, Seeff L, Diehl AM et al (1991) Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 14: 581-589.
46. Misiani R, Bellavita P, Fenili D et al (1994) Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. New England Journal of Medicine 330: 751-756.
47. Naito M, Hayashi N, Hagiwara H et al (1994) Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis. Journal of Hepatology 20: 755-759.
48. Naito M, Hayashi N, Moribe T et al (1995) Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 22: 407-412.
49. Nishiguchi S. Kuroki T, Ueda T et al (1992) Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Annals of Internal Medicine 116: 21-25.
50. Nousbaum JB, Pol S, Nalpas B et al (1995) Hepatitis C virus type 1b(II) infection in France and Italy. Annals of Internal Medicine 122: 161-168.
51. Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15: 948-963.
52. Omata M, Yokosuka O, Takano S et al (1991) Resolution of acute hepatitis C alfter therapy with natural beta interferon. Lancet 338: 914-915.
53. Pawlotsky JM, Yahia MB, Andre C et al (1994) Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19: 841-848.
54. Pawlotsky JM, Roudot-Thorval F, Simmonds Pet al (1995) Extrahepatic immunologic manifestation in chronic hepatitis C and hepatitis C virus serotypes. Annals of Internal Medicine 122: 169-173.
55. Pol S, Thiers V, Nousbaum JB et al (1995) The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108: 581-583.
56. Pontisso P, Ruvoletto MG, Fattovich G et al (1993) Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105: 1529-1533.
57. Pozzato G, Kaneko S, Moretti M et al (1994) Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. Journal of Medical Virology 43: 291-296.
58. Preston FE, Jarvis LM, Makris M et al (1995) Heterogeneity of hepatitis C virus genotypes in hemophilia; relationship with chronic liver disease. Blood 85: 1259-1262.
59. Prieto M, Olaso V, Verdu C et al (1995) Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology 22: 413-417.
60. Qian C, Camps J, Maluenda MD et al (1992) Replication of hepatitis C virus in peripheral blood mononuclear cells. Effects of alpha interferon therapy. Journal of Hepatology 16: 380-383.
61. Seeff LB, Buskell-Bales Z, Wright EC et al (1992) Long-term mortality after transfusion-associated non-A, non-B hepatitis. New England Journal of Medicine 327: 1905-1911.
62. Shindo M, Arai K, Sokawa Y & Okuno T (1995) The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 22: 418-425.
63. Silini E, Bono F, Cividini A et al (1995) Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21: 285-290.
64. Tabor E (1989) Hepatocellular carcinoma: possible etiology in patients without seologic evidence of hepatitis B virus infection. Journal of Medical Virology 27: 1-6.
65. Takano S, Yokosuka O, Imazeki F et al (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21: 650-655.
66. Tong MJ, El-Farra NS, Reikes R & Co RL (1995) Clinical outcomes after transfusion-associated hepatitis C. New England Journal of Medicine 332: 1463-1466.
67. Ueda T, Ohta K, Suzuki N et al (1992) Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. American Review of Respiratory Disease 146: 266-268.
68. Weiner AJ, Geysen HM, Christopherson C et al (1992) Evidence of immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proceeding of the National Academy of Sciences of the USA 89: 3468-3472.
69. Wiese M (1995) Natural course of hepatitis C: 15-year-analysis in an unselected group with an identical parenteral infection. Journal of Hepatology 23: 89.
70. Wright TL, Hollander H, Pu X et al (1994) Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 20: 1152-1155.
71. Yamada M, Kakumu S, Yoshioka K et al (1994) Hepatitis C virus genotypes are not responsible for development of serious liver disease. Digestive Disease and Science 39: 234-239.
72. Yamauchi M, Nakahara M, Maexawa Y et al (1993) Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. American Journal of Gastroenterology 88: 39-43.
73. Yoshiba M, Dehara K, Inoue K et al (1994) Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology 19: 829-835.
74. Zanella A, Conte D, Prati D et al (1995) Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Hepatology 21:913-917.
75. Zeldis JB & Jensen P (1994) Hepatitis C virus pathogenicity: the corner pieces of the jugsaw puzzle are found. Gastroenterology 106: 1118-1120.